Improved short-term outcomes with early use of isovolemic hemofiltration in patients with septic shock
Peter Rogiers
Correspondence Intensive Care Unit, Middelheim General Hospital, Ziekenhuisnetwerk Antwerpen, Antwerp, Belgium
Email peter.rogiers@zna.be
This article has no abstract so we have provided the first paragraph of the full text.
Sepsis and septic shock are associated with high morbidity and mortality rates, the latter ranging from 32% to 54%.1 The search for new therapeutic interventions to improve the outcome of septic shock remains challenging. One possible approach is the use of hemofiltration to remove inflammatory substances such as endotoxin, cytokines, oxygen free radicals, and arachidonic acid metabolites. This strategy forms the basis of the retrospective study by Piccinni and colleagues.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
